The House resumed from June 2 consideration of Bill C-15, An Act to amend the Controlled Drugs and Substances Act and to make related and consequential amendments to other Acts, as reported (with amendment) from the committee, and of Motion No. 1.
In the House of Commons on June 3rd, 2009. See this statement in context.